Acidosis láctica fatal en paciente con síndrome de inmunodeficiencia adquirido y tratamiento antiretroviral de alto grado de actividad: comunicación de un caso

• Autores: Martín Lasso Barreto, Jorge Pérez G, Luis Miguel Noriega, Rebeca Northland
• Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 128, Nº. 10, 2000, págs. 1139-1143
• Idioma: español
• Títulos paralelos:
  • Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with highly active antiretroviral therapy: Report of one case
• Enlaces
  • Texto completo
• Resumen

  • Type B lactic acidosis occurs without any evidence of cellular hypoxia and is associated with the use of drugs or toxins. We report a 36 years old woman with acquired immunodeficiency syndrome that was admitted to the hospital with a severe lactic acidosis. She had been treated with didanosine, stavudine and efavirenz for four months prior to admission. Despite the use of high bicarbonate doses and vasoactive drugs, the patient had a catastrophic evolution and died in shock and multiple organ failure, 68 hours after admission. (Rev Méd Chile 2000; 128: 1139-43).